BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mccormack PL, Lyseng-williamson KA. Daclatasvir in hepatitis C virus infection: a guide to its use in the EU. Drugs Ther Perspect 2016;32:42-9. [DOI: 10.1007/s40267-015-0272-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Baker MM, El-Kafrawy DS, Mahrous MS, Belal TS. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir. Ann Pharm Fr 2017;75:176-84. [PMID: 28187879 DOI: 10.1016/j.pharma.2016.12.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]